Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Cash & Equivalents (2022 - 2023)

Historic Cash & Equivalents for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to $35.4 million.

  • Lexeo Therapeutics' Cash & Equivalents fell 6234.96% to $35.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $35.4 million, marking a year-over-year decrease of 6234.96%. This contributed to the annual value of $77.3 million for FY2022, which is N/A changed from last year.
  • As of Q3 2023, Lexeo Therapeutics' Cash & Equivalents stood at $35.4 million, which was down 6234.96% from $77.3 million recorded in Q4 2022.
  • In the past 5 years, Lexeo Therapeutics' Cash & Equivalents registered a high of $94.2 million during Q3 2022, and its lowest value of $35.4 million during Q3 2023.